Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-DTBZ PET and Multi-modal MRI in Vascular Parkinsonism
NCT02195154Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Nov 2013
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Florbenazine F-18 in vascular parkinsonism (VP), sponsored by Chang Gung Memorial Hospital. Started Nov 2013; status: completed.
02
Drugs
Florbenazine F-18
03
Conditions
vascular parkinsonism (VP)
Beyond the preview
Go deeper on NCT02195154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02195154.